Protalix BioTherapeutics, Inc. (PLX) Financials

PLX Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 84.4 million 50.9 million
2023-09-30 87.6 million 49.3 million
2023-06-30 88.4 million 49.4 million
2023-03-31 66.6 million 65.6 million

PLX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 3.3 million 1.4 million
2023-09-30 -7.3 million 1.1 million
2023-06-30 4.8 million 438000
2023-03-31 -3.2 million 546000

PLX Net Income

No data available :(

PLX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 44.6 million - 6.0 million
2023-09-30 41.0 million - 5.8 million
2023-06-30 48.2 million 20.1 million 5.8 million
2023-03-31 33.0 million 28.3 million 5.3 million

PLX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 73.0 million
2023-09-30 83.8 million
2023-06-30 83.2 million
2023-03-31 57.5 million

PLX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 250000 3.1 million 4.1 million -
2023-09-30 447000 3.7 million 6.5 million 10.2 million
2023-06-30 204000 4.5 million 11.0 million 15.1 million
2023-03-31 248000 5.8 million 2.0 million 5.1 million

PLX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 10.5 million 8.9 million
2023-09-30 10.3 million 4.9 million
2023-06-30 35.1 million 6.1 million
2023-03-31 9.6 million 3.1 million

PLX

Price: $1.14

52 week price:
1.13
3.55

Earnings Per Share: 0.09 USD

P/E Ratio: 16.33

Exchange: ASE

Sector: Healthcare

Industry: Biotechnology

Volume: 637200

Market Capitalization: 88.4 million

Links: